Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of short-contact M605106 therapy in acne vulgaris
jRCT2031210011Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of M605106 in acne vulgaris (2 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Percentage change in total lesion count. Started Apr 2021; status: completed.
02
Drugs
M605106
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2031210011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210011.